The Effect of Interferon Beta and Natalizumab on miR-20b Expression in Patients with Relapsing-Remitting Multiple Sclerosis is Potentially Mediated by Modulation of the Jak-STAT Signaling Pathway: A Case-control Study.
Aysan Jafari HarandiAlireza Mirzaee SedighMitra AtaeiSepideh BayramiEmran EsmaeilzadehMohammad Hossein SanatiPublished in: Iranian journal of immunology : IJI (2024)
Our findings suggest that the positive effects of IFN-β and NTZ in the RRMS patients could be potentially mediated by returning miR-20b expression to baseline.
Keyphrases
- multiple sclerosis
- poor prognosis
- signaling pathway
- end stage renal disease
- white matter
- newly diagnosed
- dendritic cells
- peritoneal dialysis
- chronic kidney disease
- binding protein
- immune response
- prognostic factors
- epithelial mesenchymal transition
- pi k akt
- long non coding rna
- systemic lupus erythematosus
- oxidative stress